News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Luis E. Raez: Lung cancer faculty for the 2024 best of ASCO
Photo taken from Luis E. Rae/X
Jul 14, 2024, 22:09

Luis E. Raez: Lung cancer faculty for the 2024 best of ASCO

Luis E. Raez, Medical Director at Memorial Cancer Institute, shared a post on X

“Lung cancer faculty for the Memorial Cancer Institute 2024 best of ASCO with Mariano Provencio, Nagla Abdel Karim, Estela Rodriguez, Edgardo S. Santos, Delvys Rodriguez Abreu, Ignacio Gil, Meri Muminovic and Gelenis Domingo. ”

Luis E. Rae

Source: Luis E. Raez/X

ASCO cancer Delvys Rodriguez Abreu Estela Rodriguez Gelenis Domingo Ignacio Gil Luis E. Raez Memorial Cancer Institute Meri Muminovic Nagla Abdel Karim OncoDaily Oncology
Special Coverage
Insight
Jan 19, 2025, 14:19
Gustavo Viani: Breaking Barriers in Global Oncology
Insight
Jan 19, 2025, 14:17
Monica Bertagnolli: Saying Farewell and Sharing Thoughts on an Exciting Time for NIH Research
Insight
Jan 19, 2025, 14:12
Olubukola Ayodele: Breaking the Culture of Silence: Addressing Health Inequities in Black Communities
Science
Jan 19, 2025, 14:12
Khalil Choucair: Potential biomarkers of IO-therapy in patients of extremes of age
Insight
Jan 19, 2025, 14:08
Karen Knudsen: What if your grocery list could help lower your cancer risk?
Science
Jan 19, 2025, 14:08
Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma
Insight
Jan 19, 2025, 14:07
Aleix Prat: Utility of the HER2DX genomic assay in predicting pCR in HER2+ stage III IBC
Insight
Jan 19, 2025, 14:02
Cristina L.: Anti-GD2 Immunotherapy in retinoblastoma
Blog
Jan 19, 2025, 13:58
Douglas Flora: Making a real difference in cancer care delivery across the nation
Insight
Jan 19, 2025, 13:52
Amol Akhade: Datopotomab deruxtecan got approved for HR+ HER2- MBC in the third line
Insight
Jan 19, 2025, 13:47
Amy Moore: Are patients with RET+ NSCLC on TKIs protected against cachexia?
Blog
Jan 19, 2025, 13:44
Mary Feng: ASCOGI25 starts next week